NO20000706D0 - Metode for økning av biotilgjengeligheten av feksofenadin og dens derivater - Google Patents

Metode for økning av biotilgjengeligheten av feksofenadin og dens derivater

Info

Publication number
NO20000706D0
NO20000706D0 NO20000706A NO20000706A NO20000706D0 NO 20000706 D0 NO20000706 D0 NO 20000706D0 NO 20000706 A NO20000706 A NO 20000706A NO 20000706 A NO20000706 A NO 20000706A NO 20000706 D0 NO20000706 D0 NO 20000706D0
Authority
NO
Norway
Prior art keywords
foxofenadine
bioavailability
derivatives
increasing
Prior art date
Application number
NO20000706A
Other languages
English (en)
Other versions
NO20000706L (no
NO325148B1 (no
Inventor
Kin-Kai Hwang
Dennis H Giesing
Gali H Hurst
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO20000706D0 publication Critical patent/NO20000706D0/no
Publication of NO20000706L publication Critical patent/NO20000706L/no
Publication of NO325148B1 publication Critical patent/NO325148B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20000706A 1997-08-14 2000-02-11 Farmasoytisk preparat og anvendelse av en sammensetning ved fremstilling av et medikament for behandling av allergiske reaksjoner NO325148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (3)

Publication Number Publication Date
NO20000706D0 true NO20000706D0 (no) 2000-02-11
NO20000706L NO20000706L (no) 2000-04-13
NO325148B1 NO325148B1 (no) 2008-02-11

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000706A NO325148B1 (no) 1997-08-14 2000-02-11 Farmasoytisk preparat og anvendelse av en sammensetning ved fremstilling av et medikament for behandling av allergiske reaksjoner

Country Status (30)

Country Link
EP (1) EP1003528B1 (no)
JP (1) JP4295913B2 (no)
KR (1) KR100522985B1 (no)
CN (1) CN1143680C (no)
AR (1) AR018505A1 (no)
AT (1) ATE224721T1 (no)
AU (1) AU725965C (no)
BR (1) BR9811937A (no)
CA (1) CA2301267C (no)
CZ (1) CZ293666B6 (no)
DE (1) DE69808303T2 (no)
DK (1) DK1003528T3 (no)
EE (1) EE04263B1 (no)
ES (1) ES2179523T3 (no)
HK (1) HK1025901A1 (no)
HU (1) HU226823B1 (no)
ID (1) ID24463A (no)
IL (1) IL134521A (no)
NO (1) NO325148B1 (no)
NZ (1) NZ502133A (no)
OA (1) OA11287A (no)
PL (1) PL191607B1 (no)
PT (1) PT1003528E (no)
RU (1) RU2197967C2 (no)
SK (1) SK283868B6 (no)
TR (1) TR200000419T2 (no)
TW (1) TWI240633B (no)
UA (1) UA64765C2 (no)
WO (1) WO1999008690A1 (no)
ZA (1) ZA987221B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9706449A (es) * 1995-02-28 1997-11-29 Hoechst Marion Roussel Inc Composicion farmaceutica para compuestos de piperidinalcanol.
ATE238773T1 (de) * 1997-08-26 2003-05-15 Aventis Pharma Inc Arzneimittel für die kombination piperidinoalkanol-dekongestivum
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
BR0306329A (pt) * 2002-05-29 2005-04-26 Aventis Pharmaceuticals Holdin Método de tratamento de asma
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
BR112013029778A2 (pt) 2011-05-20 2017-01-17 Aventis Pharma Inc composição farmacêutica que compreende fexofenadina
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides

Also Published As

Publication number Publication date
EE200000069A (et) 2000-10-16
PL338579A1 (en) 2000-11-06
CA2301267A1 (en) 1999-02-25
CZ2000522A3 (cs) 2000-09-13
ZA987221B (en) 1999-02-15
CZ293666B6 (cs) 2004-06-16
RU2197967C2 (ru) 2003-02-10
PL191607B1 (pl) 2006-06-30
CN1267221A (zh) 2000-09-20
HU226823B1 (hu) 2009-11-30
IL134521A0 (en) 2001-04-30
AR018505A1 (es) 2001-11-28
DK1003528T3 (da) 2003-02-03
WO1999008690A1 (en) 1999-02-25
BR9811937A (pt) 2000-09-05
NZ502133A (en) 2002-03-28
JP4295913B2 (ja) 2009-07-15
KR100522985B1 (ko) 2005-10-21
CA2301267C (en) 2004-07-13
AU725965B2 (en) 2000-10-26
HUP0003189A2 (en) 2001-03-28
AU725965C (en) 2004-04-22
TR200000419T2 (tr) 2000-09-21
ES2179523T3 (es) 2003-01-16
IL134521A (en) 2005-07-25
ATE224721T1 (de) 2002-10-15
AU8505098A (en) 1999-03-08
HUP0003189A3 (en) 2001-04-28
ID24463A (id) 2000-07-20
UA64765C2 (uk) 2004-03-15
HK1025901A1 (en) 2000-12-01
CN1143680C (zh) 2004-03-31
EP1003528B1 (en) 2002-09-25
EP1003528A1 (en) 2000-05-31
OA11287A (en) 2003-10-22
SK283868B6 (sk) 2004-03-02
SK1842000A3 (en) 2000-08-14
EE04263B1 (et) 2004-04-15
TWI240633B (en) 2005-10-01
KR20010022845A (ko) 2001-03-26
DE69808303T2 (de) 2003-05-22
PT1003528E (pt) 2003-02-28
NO20000706L (no) 2000-04-13
JP2001515041A (ja) 2001-09-18
DE69808303D1 (de) 2002-10-31
NO325148B1 (no) 2008-02-11

Similar Documents

Publication Publication Date Title
NO20000227L (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse
EE200000155A (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
NO961966L (no) Fremgangsmåte for korrigering av avviksregistrering
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO20000706D0 (no) Metode for økning av biotilgjengeligheten av feksofenadin og dens derivater
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO991254L (no) FremgangsmÕter og mellomprodukter for fremstilling av substituerte kromanolderivater
NO20024058L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO20001387D0 (no) Fremgangsmåte for syntese av kinolinderivater
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO983595D0 (no) Strekkfisk og fremgangsmåte for dens tilvirkning
DE69711853T2 (de) Pyridincarboxamid-derivate
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
PL338645A1 (en) Method of obtaining substituted derivatives of 2-nitroguanidine
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
FI973780A0 (fi) Arrangemang foer bestaemning av laekemedelsdosering
FI19992066A (fi) Menetelmä sähköisessä kaupankäynnissä
UA25541A (uk) Спосіб обробки бочкоподібhих зубців

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: AVENTISUB LLC, US

MK1K Patent expired